JP2020500163A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020500163A5 JP2020500163A5 JP2019521018A JP2019521018A JP2020500163A5 JP 2020500163 A5 JP2020500163 A5 JP 2020500163A5 JP 2019521018 A JP2019521018 A JP 2019521018A JP 2019521018 A JP2019521018 A JP 2019521018A JP 2020500163 A5 JP2020500163 A5 JP 2020500163A5
- Authority
- JP
- Japan
- Prior art keywords
- ala
- controlled release
- gly
- preparation
- release preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023016292A JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410748P | 2016-10-20 | 2016-10-20 | |
| US62/410,748 | 2016-10-20 | ||
| PCT/US2017/057606 WO2018075901A1 (en) | 2016-10-20 | 2017-10-20 | Methods of delivering a neuroprotective polypeptide to the central nervous system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023016292A Division JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020500163A JP2020500163A (ja) | 2020-01-09 |
| JP2020500163A5 true JP2020500163A5 (https=) | 2024-11-28 |
| JP7626362B2 JP7626362B2 (ja) | 2025-02-07 |
Family
ID=60382598
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019521018A Active JP7626362B2 (ja) | 2016-10-20 | 2017-10-20 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
| JP2023016292A Pending JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023016292A Pending JP2023065401A (ja) | 2016-10-20 | 2023-02-06 | 中枢神経系に神経保護ポリペプチドを送達する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11273130B2 (https=) |
| EP (2) | EP4635569A3 (https=) |
| JP (2) | JP7626362B2 (https=) |
| KR (2) | KR102687778B1 (https=) |
| CN (1) | CN110191717A (https=) |
| AU (1) | AU2017345724B2 (https=) |
| BR (1) | BR112019008021A2 (https=) |
| CA (1) | CA3040906A1 (https=) |
| MX (1) | MX2019004476A (https=) |
| SG (1) | SG11201903462UA (https=) |
| WO (1) | WO2018075901A1 (https=) |
| ZA (1) | ZA201902486B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3040906A1 (en) | 2016-10-20 | 2018-04-26 | Peptron, Inc. | Methods of delivering a neuroprotective polypeptide to the central nervous system |
| JP7336813B2 (ja) * | 2019-07-29 | 2023-09-01 | ペプトロン インコーポレイテッド | レボドパ誘発性ジスキネジアの治療または進行抑制用の薬学組成物 |
| KR102552385B1 (ko) * | 2019-07-29 | 2023-07-06 | 주식회사 펩트론 | 레보도파 유발 이상 운동증의 치료 또는 진행 억제용 약학 조성물 |
| JP2023526512A (ja) | 2020-05-22 | 2023-06-21 | トラスティーズ オブ ボストン ユニバーシティ | 線維化疾患を処置するための方法および組成物 |
| CN112014193B (zh) * | 2020-07-24 | 2021-06-15 | 武汉大学中南医院 | 一种新的fj染色方法和装置 |
| US11865213B2 (en) * | 2021-07-05 | 2024-01-09 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| US12514908B2 (en) | 2021-07-05 | 2026-01-06 | Mapi Pharma Ltd. | Semaglutide depot systems and use thereof |
| CN116392576A (zh) * | 2023-05-26 | 2023-07-07 | 南通大学 | 一种gip受体激动剂在制备治疗脊髓损伤修复靶点药物中的应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US5609885A (en) | 1992-09-15 | 1997-03-11 | Alza Corporation | Osmotic membrane and delivery device |
| US6132420A (en) | 1996-02-02 | 2000-10-17 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
| US6156331A (en) | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| US6261584B1 (en) | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| US6395292B2 (en) | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
| NZ331186A (en) | 1996-02-02 | 2000-04-28 | Alza Corp | Osmotically driven sustained delivery drug delivery capsule |
| ZA981610B (en) | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
| MY125849A (en) | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| ES2293688T5 (es) | 1997-08-08 | 2011-05-04 | Amylin Pharmaceuticals, Inc. | Nuevos compuestos análogos de la exendina. |
| ATE383867T1 (de) | 1997-11-14 | 2008-02-15 | Amylin Pharmaceuticals Inc | Neuartige exendin agonisten |
| AU1623099A (en) | 1997-12-22 | 1999-07-12 | Alza Corporation | Rate controlling membranes for controlled drug delivery devices |
| WO1999033446A1 (en) | 1997-12-29 | 1999-07-08 | Alza Corporation | Osmotic delivery system with membrane plug retention mechanism |
| KR100568917B1 (ko) | 1997-12-30 | 2006-04-07 | 알자 코포레이션 | 멤브레인 플러그를 갖는 익제 전달장치 |
| EP1140014B1 (en) | 1998-12-31 | 2003-03-19 | Alza Corporation | Osmotic delivery system having space efficient piston |
| ES2248156T3 (es) | 1999-12-21 | 2006-03-16 | Alza Corporation | Valvula para dispositivos osmoticos. |
| US7163688B2 (en) | 2001-06-22 | 2007-01-16 | Alza Corporation | Osmotic implant with membrane and membrane retention means |
| ATE408414T1 (de) | 2001-07-31 | 2008-10-15 | Us Gov Health & Human Serv | Glp 1 exendin 4 peptidanaloga und deren verwendungen |
| DE60317225T2 (de) | 2002-06-26 | 2008-05-29 | Intarcia Therapeutics, Inc., Emeryville | Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme |
| US7014636B2 (en) | 2002-11-21 | 2006-03-21 | Alza Corporation | Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
| DE602004012081T2 (de) | 2003-03-31 | 2009-03-19 | Intarcia Therapeutics, Inc., Emeryville | Osmotische pumpe mit mitteln zum ableiten des innendrucks |
| US20080318837A1 (en) * | 2003-12-26 | 2008-12-25 | Nastech Pharmaceutical Company Inc. | Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide |
| US20050175701A1 (en) | 2004-02-10 | 2005-08-11 | Alza Corporation | Capillary moderator for osmotic delivery system |
| WO2006014425A1 (en) | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
| US8168222B2 (en) * | 2004-09-07 | 2012-05-01 | Board Of Regents Of The University Of Nebraska | Amphiphilic polymer-protein conjugates and methods of use thereof |
| KR101106510B1 (ko) | 2006-05-30 | 2012-01-20 | 인타르시아 세라퓨틱스 인코포레이티드 | 투피스, 내부채널 삼투압 전달 시스템 유동 조절기 |
| EP2359808B1 (en) | 2006-08-09 | 2013-05-22 | Intarcia Therapeutics, Inc | Osmotic delivery systems and piston assemblies |
| KR100805208B1 (ko) * | 2007-03-27 | 2008-02-21 | 주식회사 펩트론 | 엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법 |
| WO2008133908A2 (en) | 2007-04-23 | 2008-11-06 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
| RU2547990C2 (ru) | 2009-09-28 | 2015-04-10 | Интарсия Терапьютикс, Инк. | Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства |
| US9259432B1 (en) * | 2011-01-31 | 2016-02-16 | Parminder J. S. Vig | Composition and methods for targeted delivery of a therapeutic compound to the brain or spinal cord of a subject for treatment of neurodegenerative diseases |
| WO2012177929A2 (en) * | 2011-06-24 | 2012-12-27 | Amylin Pharmaceuticals, Inc. | Methods for treating diabetes with extended release formulations of glp-1 receptor agonists |
| JP6226510B2 (ja) | 2012-01-27 | 2017-11-08 | キヤノン株式会社 | 画像処理システム、処理方法及びプログラム |
| ITMI20130325A1 (it) | 2013-03-05 | 2014-09-06 | Telecom Italia Spa | Metodo per misurare e monitorare il livello di accesso a dati personali generati da risorse di un dispositivo d'utente |
| JP2015192425A (ja) | 2014-03-28 | 2015-11-02 | 富士通株式会社 | デマンド収容変更順序決定方法、およびデマンド収容変更順序決定プログラム |
| US20170035856A1 (en) * | 2014-04-16 | 2017-02-09 | Shandong Luye Pharmaceutical Co., Ltd. | Exenatide-containing composition and preparation method therefor |
| CA3040906A1 (en) | 2016-10-20 | 2018-04-26 | Peptron, Inc. | Methods of delivering a neuroprotective polypeptide to the central nervous system |
-
2017
- 2017-10-20 CA CA3040906A patent/CA3040906A1/en active Pending
- 2017-10-20 EP EP25181393.7A patent/EP4635569A3/en active Pending
- 2017-10-20 BR BR112019008021A patent/BR112019008021A2/pt unknown
- 2017-10-20 EP EP17800650.8A patent/EP3528836A1/en not_active Withdrawn
- 2017-10-20 SG SG11201903462UA patent/SG11201903462UA/en unknown
- 2017-10-20 JP JP2019521018A patent/JP7626362B2/ja active Active
- 2017-10-20 KR KR1020217022385A patent/KR102687778B1/ko active Active
- 2017-10-20 US US16/342,685 patent/US11273130B2/en active Active
- 2017-10-20 WO PCT/US2017/057606 patent/WO2018075901A1/en not_active Ceased
- 2017-10-20 AU AU2017345724A patent/AU2017345724B2/en active Active
- 2017-10-20 KR KR1020197014421A patent/KR20190086460A/ko not_active Ceased
- 2017-10-20 MX MX2019004476A patent/MX2019004476A/es unknown
- 2017-10-20 CN CN201780078697.6A patent/CN110191717A/zh active Pending
-
2019
- 2019-04-17 ZA ZA2019/02486A patent/ZA201902486B/en unknown
-
2021
- 2021-11-09 US US17/522,687 patent/US11771657B2/en active Active
-
2023
- 2023-02-06 JP JP2023016292A patent/JP2023065401A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020500163A5 (https=) | ||
| EP2134329B1 (en) | Composition and microsphere for controlled-release of exendin, and method of preparing the same | |
| ES2552646T3 (es) | Exendinas para disminuir el colesterol y los triglicéridos | |
| Lacroix et al. | The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations | |
| US6495120B2 (en) | Formulation and system for intra-oral delivery of pharmaceutical agents | |
| CN101600417B (zh) | 用于神经递质的经鼻施用的控制释放递送系统 | |
| CA2320371A1 (en) | Inotropic and diuretic effects of exendin and glp-1 | |
| JP7626362B2 (ja) | 中枢神経系に神経保護ポリペプチドを送達する方法 | |
| JP2002500193A (ja) | 単量体インシュリンアナログの投与方法 | |
| CN101588789B (zh) | 用于治疗牛和其它动物炎症的药物组合物和方法 | |
| MX2008016254A (es) | Uso de agonistas del receptor de adenosina a2a en el tratamiento de isquemia. | |
| WO2003004031A1 (en) | Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic | |
| AU2002318211A1 (en) | Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic | |
| US20120040970A1 (en) | Intranasal delivery system for dantrolene | |
| Minchin et al. | Pulmonary toxicity of doxorubicin administered by in situ isolated lung perfusion in dogs | |
| WO2022046976A1 (en) | An epinephrine injection formulation with very low epinephrine concentration and low impurities during its shelf-life | |
| WO2019193417A1 (en) | Composition and method of reducing joint pain associated with hemarthrosis | |
| Desai et al. | Nanotechnology-based mucoadhesive and mucus-penetrating drug-delivery systems for transbuccal drug delivery | |
| US9161910B2 (en) | Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type II diabetes | |
| Ramsay | Pharmacokinetics and clinical use of parenteral phenytoin, phenobarbital, and paraldehyde | |
| US20050004221A1 (en) | Intrathecal gabapentin compositions | |
| US20140377365A1 (en) | Sustained-release formulation of rotigotine | |
| JP7518149B2 (ja) | 高濃度インスリン製剤 | |
| KR20170099911A (ko) | 파라세타몰 주사 제제 | |
| WO2017015691A1 (de) | Konzentrat enthaltend alprostadil |